Voloridge Investment Management, LLC Allakos Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.6 - $5.25 $1.19 Million - $1.74 Million	-330,892 Reduced 93.7%	22,253 $97,000
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $136,873 - $263,242	-31,831 Reduced 8.27%	353,145 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $2.18 Million - $3.24 Million	384,976 New	384,976 $3.24 Million
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $337,654 - $797,383	-129,867 Reduced 17.96%	593,044 $1.86 Million
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $222,910 - $430,462	43,880 Added 6.46%	722,911 $4.12 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $5.46 Million - $71.5 Million	638,780 Added 1586.99%	679,031 $6.65 Million
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $3.78 Million - $5.45 Million	-49,393 Reduced 55.1%	40,251 $4.26 Million
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $177,825 - $237,670	-2,083 Reduced 2.27%	89,644 $7.65 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $7.32 Million - $10.2 Million	66,697 Added 266.47%	91,727 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.99 Million - $3.82 Million	25,030 New	25,030 $3.5 Million
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $1.09 Million - $1.99 Million	-24,654 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $945,412 - $1.98 Million	21,250 Added 624.27%	24,654 $1.1 Million
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $2.41 Million - $4.99 Million	-36,250 Reduced 91.42%	3,404 $325,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $1.23 Million - $3.56 Million	39,654 New	39,654 $3.12 Million
Q2 2019 Aug 14, 2019	SELL	$36.0 - $44.73 $527,292 - $655,160	-14,647 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $494,922 - $761,497	14,647 New	14,647 $593,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account